Rotavirus

Vaccine Performs Well in Tests

Published in Vaccine Weekly, May 15th, 1995

A researcher who is developing a vaccine against an illness that kills more than 870,000 children a year said it has performed well in tests.

More than 80 percent of the most severe illnesses caused by rotavirus were prevented among infants receiving the vaccine, Dr. David Bernstein of the J.N. Gamble Institute of Medical Research in Cincinnati, Ohio, told the Columbus Dispatch.

He said an effective vaccine against rotavirus could prevent more than one million cases annually in children in the United States and could prevent about 65,000 youngsters from being hospitalized.

The vaccine, developed by the U.S. National Institute of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-05-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry